Table 2.
Properties | Virus | Animal/cell cultures | Effects of melatonin administration | Ref. |
---|---|---|---|---|
Free radical scavenger | VEEV | Murine splenocytes | Reduction of NO• concentrations in tissue | 105 |
Murine neuroblastoma | Decrease of both NO• and lipid peroxidation | 106 | ||
Mice | Reduces nitrite concentrations in the brain and serum | 107 | ||
Lowering lipid peroxidation products | ||||
RSV | Mice | Reduction of acute lung oxidative injury | 31 | |
Suppression of MDA, NO• and •OH generation | ||||
Restoration of GSH and SOD levels in the lungs | ||||
Antioxidant enzyme inducer | RHDV | Rabbits | Restoration of activity and mRNA expression of GPx, GST and Mn‐SOD | 109 |
Rise in protein expression of Nrf2 | ||||
Regulator of immune functions | MLV | Mice | Prevention of reduction in B‐ and T‐cell proliferation | 156 |
Prevention in Th1 cytokine secretion | ||||
Prevention of overproduction of Th2 cytokines and TNF‐α | ||||
VEEV | Mice | Stimulation of endogenous production of IL‐1β in brain | 158 | |
Reduction of the concentration of TNF‐α in brain | ||||
Stimulation of endogenous production of IFN‐γ, IL‐1β, and TNF‐α in serum | 159 | |||
RSV | Mouse macrophages | Decrease of TLR3‐mediated downstream gene expression | 170 | |
Regulator of PCD | RHDV | Rabbits | Reduction of Bax expression | 179 |
Reduction of cytosolic cytochrome c release | ||||
Increased expression of Bcl‐2 and Bcl‐xL | ||||
Inhibition of caspase‐9 activity | ||||
Reduction in caspase‐8 activity | ||||
Reduction in TNF‐R1 and JNK expression | ||||
Increased expression of c‐FLIP |
VEEV, Venezuelan equine encephalomyelitis virus; RHDV, rabbit hemorrhagic disease virus; MLV, murine leukemia virus.